Revenue | ₹571.17Cr |
Net Profits | ₹74.08Cr |
Net Profit Margins | 12.97% |
Cohance Lifesciences Ltd’s revenue fell -7.87% since last year same period to ₹571.17Cr in the Q2 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated 1.36% jump in its revenue since last 3-months.
Cohance Lifesciences Ltd’s net profit fell -46.5% since last year same period to ₹74.08Cr in the Q2 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated 51.55% jump in its net profits since last 3-months.
Cohance Lifesciences Ltd’s net profit margin fell -41.93% since last year same period to 12.97% in the Q2 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated 49.51% jumped in its net profit margins since last 3-months.
The revenue for Cohance Lifesciences Ltd in the Q2 results 2025 was ₹571.17Cr.
The net profit for Cohance Lifesciences Ltd in the Q2 results 2025 was ₹74.08Cr.
The net profit margin for Cohance Lifesciences Ltd in the Q2 results 2025 was 12.97%.
The revenue for Cohance Lifesciences Ltd in the Q2 results 2024 was ₹619.96Cr.
The net profit for Cohance Lifesciences Ltd in the Q2 results 2024 was ₹138.47Cr.
The net profit margin for Cohance Lifesciences Ltd in the Q2 results 2024 was 22.34%.